Rochester, MN, United States of America

Krishna R Kalari

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Krishna R. Kalari in Cancer Research

Introduction

Krishna R. Kalari, based in Rochester, MN, is a notable inventor with a significant contribution to oncology through his innovative patent. His work, particularly in assessing chemotherapy responsiveness and treating cancer, has the potential to advance cancer treatment and improve patient outcomes.

Latest Patents

Kalari holds one patent titled "Methods and materials for assessing chemotherapy responsiveness and treating cancer." This patent outlines various methods and materials for determining a cancer patient's likelihood of responding to chemotherapy, specifically focusing on breast cancer. It emphasizes the role of a variant in the polycystic kidney disease gene 1 (PKD1) and introduces methods to treat mammals with breast cancer through the administration of specific inhibitors in combination with other chemotherapeutic agents.

Career Highlights

Krishna R. Kalari is associated with the Mayo Foundation for Medical Education and Research, where he has been instrumental in advancing the field of cancer treatment. His patent represents a culmination of extensive research aiming to enhance the efficacy of chemotherapy regimens, with a particular focus on personalizing treatment for breast cancer patients.

Collaborations

Throughout his career, Kalari has collaborated with notable professionals, including Matthew P. Goetz and Judy C. Boughey. These collaborations reflect a shared commitment to innovative research and a deep understanding of cancer treatment modalities.

Conclusion

Krishna R. Kalari's work is a prime example of how inventive thinking in the medical field can lead to breakthroughs that significantly impact patient care. His patent not only addresses current challenges in oncology but also paves the way for future innovations in cancer treatment and research. Through his ongoing efforts at the Mayo Foundation for Medical Education and Research, Kalari continues to make strides in improving cancer responsiveness assessment and therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…